Behavioral reactivity and addiction: the adaptation of behavioral response to reward opportunities

Journal of Neuropsychiatry and Clinical Neurosciences

Volumn 20, Issue 1, 2008, Pages 23-35

  Trafton, Jodie A ^a,b   Gifford, Elizabeth V ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CENTER FOR HEALTH CARE EVALUATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; BROMOCRIPTINE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DOPAMINE RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; METHAMPHETAMINE; NEUROTRANSMITTER;

ADAPTIVE BEHAVIOR; ADDICTION; ARTICLE; BEHAVIOR; BEHAVIOR THERAPY; BEHAVIORAL REACTIVITY; BRAIN; BRAIN REGION; COGNITIVE THERAPY; CONCEPTUAL FRAMEWORK; DOPAMINE RELEASE; DRUG DEPENDENCE; DRUG DEPENDENCE TREATMENT; DRUG MEGADOSE; GENE EXPRESSION; GENETIC POLYMORPHISM; GENETICS; HUMAN; NERVE CELL; NERVE EXCITABILITY; NERVE POTENTIAL; NEUROBIOLOGY; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSYCHOSOCIAL CARE; PSYCHOTHERAPY; REINFORCEMENT; RESEARCH; REWARD; REWARD OPPORTUNITY; SIGNAL TRANSDUCTION; SMOKING CESSATION;

EID: 39749134112     PISSN: 08950172     EISSN: None     Source Type: Journal    
DOI: 10.1176/jnp.2008.20.1.23     Document Type: Article

References (78)

1. Kreek MJ, Nielsen DA, Butelman ER, et al: Genetic influences on impulsivity, risk taking, stress responsivity and vulnerability to drug abuse and addiction. Nat Neurosci 2005; 8:1450-1457
2. Weiss F: Neurobiology of craving, conditioned reward and relapse. Curr Opin Pharmacol 2005; 5:9-19
3. Koob GF, Ahmed SH, Boutrel B, et al: Neurobiological mechanisms in the transition from drug use to drug dependence. Neurosci Biobehav Rev 2004; 27:739-749
4. Schultz W: Behavioral theories and the neurophysiology of reward. Annu Rev Psychol 2006; 57:87-115
5. Tobler PN, Fiorillo CD, Schultz W: Adaptive coding of reward value by dopamine neurons. Science 2005; 307:1642-1645
6. Hyman SE, Malenka RC, Nestler EJ: Neural mechanisms of addiction: the role of reward-related learning and memory. Annu Rev Neurosci 2006; 29:565-598
7. Marlatt GA, Gordon JR: Relapse Prevention: Maintenance Strategies in the Treatment of Addictive Behaviors. New York, Guilford, 1985
8. Higgins ST, Petry NM: Contingency management: incentives for sobriety. Alcohol Res Health 1999; 23:122-127
9. Meyers RJ, Miller WR: A Community Reinforcement Approach to Addiction Treatment. Cambridge, MA, Cambridge University Press, 2001
10. O'Farrell T, Fals-Stewart W: Behavioral couples therapy for alcoholism and drug abuse. J Substance Abuse Treatment 2000; 18:51-54
11. Rosenfield PL: The potential of transdisiciplinary research for sustaining and extending linkages between the health and social sciences. Soc Sci Med 1992; 35:1343-1357
12. Abrams DB: Transdisciplinary paradigms for tobacco prevention research. Nicotine Tob Res 1999; 1:S15-23
13. Abrams DB, Leslie F, Mermelstein R, et al: Transdisciplinary tobacco use research. Nicotine Tob Res 2003; 5(S1):S5-10
14. Tiffany ST, Conklin CA, Shiftman S, et al: What can dependence theories tell us about assessing the emergence of tobacco dependence? Addiction 2004; 99(S1):78-86
15. West R: Theory of Addiction. Oxford, UK, Blackwell Scientific Publishing, 2006
16. Barrot M, Olivier JD, Perrotti LI, et al: CREB activity in the nucleus accumbens shell controls gating of behavioral responses to emotional stimuli. Proc Natl Acad Sci USA 2002; 99:11435-11440
17. Sanchis-Seguar C, Spanagel R: Behavioural assessment of drug reinforcement and addictive features in rodents: an overview. Addict Biol 2006; 11:2-38
18. Hole K, Tjolsen A: The tail-flick and formalin tests in rodents: changes in skin temperature as a confounding factor. Pain 1993; 53:247-254
19. Brown RA, Lejuez CW, Kahler CW: Distress tolerance and early smoking lapse. Clin Psychol Rev 2005; 25:713-733
20. Hayes SC, Bissett RT, Korn Z, et al: The impact of acceptance versus control rationales on pain tolerance. Psychol Rec 1999; 49:33-47
21. Brown RA, Lejuez CW, Kahler CW, et al: Distress tolerance and duration of past smoking cessation attempts. J Abnorm Psychol 2002; 111:180-185
22. Barrot M, Wallace DL, Bolanos CA, et al: Regulation of anxiety and initiation of sexual behavior by CREB in the nucleus accumbens. Proc Natl Acad Sci USA 2005; 102:8357-8362
23. Nicola SM, Yun IA, Wakabayshi KT, et al: Cue-evoked firing of nucleus accumbens neurons encodes motivational significance during a discriminative stimulus task. J Neurophysiol 2004; 91: 1840-1865
24. Mogenson GJ, Jones DL, Yim CY: From motivation to action: functional interface between the limbic system and the motor system. Prog Neurobiol 1980; 14:69-97
25. Taha SA, Fields HL: Inhibitions of nucleus accumbens neurons encode a gating-signal for reward directed behavior. J Neurosci 2006; 26:217-222
26. Fong GW, Knutson B, Risinger RC: Hyperactivation of reward-related mesolimbic areas in alcoholics who subsequently relapse. Human Brain Mapping Conference, Toronto, Canada, June 12-16, 2005
27. Knutson B, Westdorp A, Kaiser E: fMRI visualization of brain activity during a monetary incentive delay task. Neuroimage 2000; 12:20-27
28. Knutson B, Adams CS, Fong GW: Anticipation of monetary reward selectively recruits nucleus accumbens. J Neurosci 2001; 21:RC159
29. Knutson B, Fong GW, Adams CS: Dissociation of reward anticipation versus outcome with event-related fMRI. Neuroreport 2001; 12:3683-3687
30. Knutson B, Taylor J, Kaufman M: Distributed neural representation of expected value. J Neurosci 2005; 25:4806-4812
31. Bressan RA, Crippa JA: The role of dopamine in reward and pleasure behaviour: review of data from preclinical research. Acta Psychiatr Scand 2005; 427(Suppl):14-21
32. Schultz W: Predictive reward signal of dopamine neurons. J Neurophysiol 1998; 80:1-27
33. Waelti P, Dickenson A, Schultz W: Dopamine responses comply with basic assumptions of formal learning theory. Nature 2001; 412:43-48
34. Volkow ND, Wang GJ, Fowler JS, et al: "Nonhedonic" food motivation in humans involves dopamine in the dorsal striatum and methylphenidate amplifies this effect. Synapse 2002; 44:175-180
35. Konradi C, Cole RL, Heckers S, et al: Amphetamine regulates gene expression in rat striatum via transcription factor CREB. J Neurosci 1994; 14:5623-5634
36. Dudman JT, Eaton ME, Rajadhyaksha A, et al: Dopamine D1 receptors mediate CREB phosphorylation via phosphorylation of the NMDA receptor at Ser897-NR1. J Neurochem 2003; 87: 922-934
37. Yan Z, Feng J, Fienberg AA, et al: D2 dopamine receptors induce mitogen-activated protein kinase and camp response element-binding protein phosphorylation in neurons. Proc Natl Acad Sci USA 1999; 96:11607-11612
38. Brami-Cherrier K, Valjent E, Garcia M, et al: Dopamine induces a PI3-kinase-independent activation of AKT in striatal neurons: a new route to camp response element-binding protein phosphorylation. J Neurosci 2002; 22:8911-8921
39. Shaw-Lutchman TZ, Impey S, Storm D, et al: Regulation of CRE-mediated transcription in mouse brain by amphetamine. Synapse 2003; 48:10-17
40. Jang CG, Lee SY, Lee HK, et al: Time courses of pCREB expression after dopaminergic stimulation by apomorphine in mouse brain. Arch Pharm Res 2002; 25:370-374
41. McClung CA, Nestler EJ: Regulation of gene expression and cocaine reward by CREB and deltaf osb. Nat Neurosci 2003; 6:1208-1215
42. Dong Y, Green T, Saal D, et al: CREB modulates excitability of nucleus accumbens neurons. Nat Neurosci 2006; 9:475-477
43. Newton SS, Thome J, Wallace TL, et al: Inhibition of camp response element-binding protein or dynorphin in the nucleus accumbens produces an antidepressant-like effect. J Neurosci 2002; 22:10883-10890
44. Pliakas AM, Carlson RR, Neve RL, et al: Altered responsiveness to cocaine and increased immobility in the forced swim test associated with elevated camp response element-binding protein expression in nucleus accumbens. J Neurosci 2001; 21:7397-7403
45. Carlezon WA Jr, Thome J, Olson VG, et al: Regulation of cocaine reward by CREB. Science 1998; 282:2272-2275
46. Green TA, Alibhai IN, Hommel JD, et al: Induction of inducible camp early repressor expression in nucleus accumbens by stress or amphetamine increases behavioral responses to emotional stimuli. J Neurosci 2006; 26:8235-8242
47. McClure SM, Daw ND, Montague PR: A computational substrate for incentive salience. Trends Neurosci 2003; 26:423-428
48. Morris G, Nevet A, Arkadir D, et al: Midbrain dopamine neurons encode decisions for future action. Nat Neurosci 2006; 9:1057-1063
49. Pessiglione M, Seymour B, Flandin G, et al: Dopamine-dependent prediction errors underpin reward-seeking behaviour in humans. Nature 2006; 442:1042-1045
50. Argyelan M, Szabo Z, Kanyo B, et al: Dopamine transporter availability in medication free and in bupropion treated depression: a 99mTc-TRODAT-1 SPECT study. J Affect Disord 2005; 89: 115-123
51. Stahl SM, Pradko JF, Height BR, et al: A review of the neuropharmacology of bupropion, a dual norepinephrine and dopamine reuptake inhibitor. Prim Care Companion J Clin Psychiatry 2004; 6:159-166
52. Learned-Coughlin SM, Bergstrom M, Savitcheva I, et al: In vivo activity of bupropion at the human dopamine transporter as measured by positron emission tomography. Biol Psychiatry 2003; 54:800-805
53. Van Etten ML, Higgins ST, Budney AJ, et al: Comparison of the frequency and enjoyability of pleasant events in cocaine abusers vs. non-abusers using a standardized behavioral inventory. Addiction 1998; 93:1669-1680
54. Bruijnzeel AW, Markou A: Characterization of the effects of bupropion on the reinforcing properties of nicotine and food in rats. Synapse 2003; 50:20-28
55. Rauhut AS, Neugebauer N, Dwoskin LP, et al: Effect of bupropion on nicotine self-administration in rats. Psychopharmacology 2003; 169:1-9
56. Eshleman AJ, Henningsen RA, Neve KA, et al: Release of dopamine via the human transporter. Mol Pharmacol 1994; 45:312-316
57. Anden NE, Rubenson A, Fuxe K, et al: Evidence for dopamine receptor stimulation by apomorphine. J Pharm Pharmacol 1967; 19:627-629
58. Colpaert FC, Van Bever WF, Leysen JE: Apomorphine: chemistry, pharmacology, biochemistry. Int Rev Neurobiol 1976; 19:225-268
59. Bardo MT, Klebaur JE, Valone JM, et al: Environmental enrichment decreases intravenous self-administration of amphetamine in female and male rats. Psychopharmacol 2001; 155:278-284
60. Green TA, Gehrke BJ, Bardo MT: Environmental enrichment decreases intravenous amphetamine self-administration in rats: dose-response functions for fixed- and progressive-ratio schedules. Psychopharmacology 2002; 162:373-378
61. Morgan D, Grant KA, Gage HD, et al: Social dominance in monkeys: dopamine D2 receptors and cocaine self-administration. Nat Neurosci 2002; 5:169-174
62. Richmond R, Zwar N: Review of bupropion for smoking cessation. Drug Alcohol Rev 2003; 22:203-220
63. Hughes J, Stead L, Lancaster T: Antidepressants for smoking cessation. Cochrane Database Syst Rev 2004; 4:CD000031
64. Torrens M, Fonseca F, Mateu G, et al: Efficacy of antidepressants in substance use disorders with and without comorbid depression: a systematic review and meta-analysis. Drug Alcohol Depend 2005; 78:1-22
65. Caskey NH, Jarvik ME, Wirshing WC, et al: Modulating tobacco smoking rates by dopaminergic stimulation and blockade. Nicotine Tob Res 2002; 4:259-266
66. Murphy MF, Hey K, Johnstone E, et al: Bromocriptine use is associated with decreased smoking rates. Addict Biol 2002; 7:325-328
67. Soares BG, Lima MS, Reisser AA, et al: Dopamine agonists for cocaine dependence. Cochrane Database Syst Rev 2003; 2: CD003352
68. Nowinski J, Baker S, Carroll KM: Twelve Step Facilitation Therapy Manual (NIH Publication No. 94-3722). Rockville, MD, National Institutes of Health, 1995
69. Miller WR, Rollnick S: Motivational Interviewing: Preparing People for Change, 2nd ed. New York, Guilford Press, 2002
70. Hayes SC, Wilson KG, Gifford EV: The use of twelve-step facilitation and acceptance and commitment therapy with polysubstance abusing methadone maintained opiate addicts: a randomized controlled trial. Behav Ther 2004; 35:679-688
71. McCrady BS, Irvine S: Self-help groups, in Handbook of Alcoholism Treatment Approaches. Edited by Hester RK, Miller W. New York, Pergamon Press, 1989, pp 153-169
72. Gifford EV, Ritsher JB, McKellar JD, et al: Acceptance and relationship context: a model of substance use disorder treatment outcome. Addiction 2006; 101:1167-1177
73. Gifford EV, Humphreys KN: The psychological science of addiction. Addiction 2007; 102:352-361
74. Stead LF, Lancaster T: Group behavior therapy programmes for smoking cessation. Cochrane Database Syst Rev 2005; 2:CD001007
75. Blum K, Braverman ER, Holder JM, et al: Reward deficiency syndrome: a biogenetic model for the diagnosis and treatment of impulsive, addictive, and compulsive behaviors. J Psychoactive Drugs 2000; 32(S1-4):1-112
76. Comings DE, Blum K: Reward deficiency syndrome: genetic aspects of behavioral disorders. Prog Brain Res 2000; 126:325-341
77. Volkow ND, Fowler JS, Wang GJ, et al: Dopamine in drug abuse and addiction: results from imaging studies and treatment implications. Mol Psychiatry 2004; 9:557-569
78. Noble EP: The DRD2 gene in psychiatric and neurological disorders and its phenotypes. Pharmacogenomics 2000; 1:309-333